Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Legacy Hazardous Drugs
Do Not Tube List
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Report an iCare
Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Legacy Hazardous Drugs
Do Not Tube List
Search results for:
palivizumab
palivizumab
Drug Name
Form
Strength
Notes
Synagis
SOLUTION, INTRAMUSCULAR
100 mg/mL
VIEW MORE
Monoclonal Antibodies
Additional Information:
Drug Name
Common Side Effects
palivizumab
fever
rash
hypersensitivity reaction
Non-Formulary
- Palivizumab is no longer recommended by American Academy of Pediatric and will not be manufactured moving forward. See
FormWeb • nirsevimab
.
Last updated:
Oct. 17, 2025
Restricted
Formulary Restricted Medication
Micromedex
CareNotes
UpToDate
Facts & Comparisons
MedLinePlus (Patient Information)
Add Formweb to your mobile device
palivizumab